Hematología y Hemoterapia
![Foto de Hematología y Hemoterapia](/img/grupo.png)
![Foto de Hospital de la Santa Creu i Sant Pau](/img/noimage_org.png)
Hospital de la Santa Creu i Sant Pau
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital de la Santa Creu i Sant Pau (6)
2022
-
Pharmacokinetic and clinical improvements after PK-guided switch from standard half-life to extended half-life factor VIII products
Thrombosis Research, Vol. 216, pp. 35-42
2021
-
A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients
Blood Cells, Molecules, and Diseases, Vol. 86
-
Author Correction: Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia (Scientific Reports, (2019), 9, 1, (16680), 10.1038/s41598-019-53209-y)
Scientific Reports
-
Expert opinion paper on the treatment of hemophilia B with albutrepenonacog alfa
Expert Opinion on Biological Therapy, Vol. 21, Núm. 9, pp. 1165-1171
-
Management of acquired hemophilia A: results from the Spanish registry
Blood Advances, Vol. 5, Núm. 19, pp. 3821-3829